INJECT ApS: Financial statements 2013
CVR: 33867581
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
INJECT ApS (CVR 33867581) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -14,364 and a net result of DKK -14,364. Equity in the 2013 report amounted to DKK 588,290. The solvency ratio was 20.6%.
- Gross Profit
- DKK -14,364
- Profit/Loss
- DKK -14,364
- Equity
- DKK 588,290
- Total Assets
- DKK 2,861,608
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
INJECT ApS has published its interim report for the period August 3, 2011 – December 31, 2012.
As of July 21, 2013, SLOT IX ApS has stepped down as auditor of INJECT ApS.
As of June 26, 2013, Lars Wexøe is registered as director of INJECT ApS.
As of June 26, 2013, John Holger Adamsen has stepped down as adm. dir. of INJECT ApS.
As of March 22, 2013, John Holger Adamsen is registered as adm. dir. of INJECT ApS.
As of March 22, 2013, Mikael Hans Andranik Hetting has stepped down as director of INJECT ApS.
About INJECT ApS
INJECT ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2011. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The management consists of Felix Hetting. The company is owned by MAFO ApS, Tina Hetting Holding I ApS and ASYRINGE LIMITED. According to the 2019 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK 0.